Dual-functional conjugates improving cancer immunochemotherapy by inhibiting tubulin polymerization and indoleamine-2,3-dioxygenase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual-functional conjugates improving cancer immunochemotherapy by inhibiting tubulin polymerization and indoleamine-2,3-dioxygenase

Published:2020-03 Issue: Volume:189 Page:112041
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Hua Shixian,Chen Feihong,Wang Xinyi,Gou Shaohua^ORCID

Funder

National Natural Science Foundation of China

Zhishan Youth Scholar Program of SEU

Fundamental Research Funds for the Central Universities

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference66 articles.

1. The immunobiology of cancer immunosurveillance and immunoediting;Dunn;Immunity,2004

2. Clinical application of genetically modified T cells in cancer therapy;Kershaw;Clin. Transl. Immunol.,2014

3. Immunosuppressive networks in the tumour environment and their therapeutic relevance;Zou;Nat. Rev. Cancer,2005

4. Cancer immunotherapy comes of age;Mellman;Nature,2011

5. Prospects for gene-engineered T cell immunotherapy for solid cancers;Klebanoff;Nat. Med.,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential Strategies for Overcoming Multidrug Resistance and Reducing Side Effects of Monomer Tubulin Inhibitors for Cancer Therapy;Current Medicinal Chemistry;2024-04

2. An update on the recent advances and discovery of novel tubulin colchicine binding inhibitors;Future Medicinal Chemistry;2023-01

3. Research status of indole-modified natural products;RSC Medicinal Chemistry;2023

4. Novel combretastatin A-4 derivative containing aminophosphonates as dual inhibitors of tubulin and matrix metalloproteinases for lung cancer treatment;European Journal of Medicinal Chemistry;2022-12

5. Recent advances in combretastatin A-4 codrugs for cancer therapy;European Journal of Medicinal Chemistry;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3